1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 2: 
Summary of positive provocative test results
Agent and VesselChangeNo. of Procedures (n = 19)
Sodium amytal
 PSAUnilateral MEP1
 ASAUnilateral MEP2
 ASABilateral BCR, unilateral MEP1*
Lidocaine
 PSABilateral MEP1
 PSABilateral MEP and SEP1
 PSAUnilateral MEP1
 PSAUnilateral SEP1
 PSAUnilateral MEP and BCR2
 ASAUnilateral MEP4
 ASABilateral MEP4
 PICAUnilateral MEP1
  • * MEPs and SEPs were monitored from only one leg because of previous amputation of the other leg.